1. Home
  2. VNRX vs LCFY Comparison

VNRX vs LCFY Comparison

Compare VNRX & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VolitionRX Limited

VNRX

VolitionRX Limited

BUY

Current Price

$0.17

Market Cap

7.2M

Sector

Health Care

ML Signal

BUY

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$1.18

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNRX
LCFY
Founded
N/A
2009
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
8.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
VNRX
LCFY
Price
$0.17
$1.18
Analyst Decision
Buy
Analyst Count
5
0
Target Price
★ $13.62
N/A
AVG Volume (30 Days)
★ 1.5M
57.1K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 38.00
N/A
EPS
N/A
★ N/A
Revenue
★ $1,727,384.00
N/A
Revenue This Year
$57.67
N/A
Revenue Next Year
$240.52
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40.04
N/A
52 Week Low
$0.13
$1.20
52 Week High
$3.26
$6.20

Technical Indicators

Market Signals
Indicator
VNRX
LCFY
Relative Strength Index (RSI) 22.79 24.39
Support Level $0.15 N/A
Resistance Level $0.18 $2.75
Average True Range (ATR) 0.02 0.24
MACD 0.01 -0.08
Stochastic Oscillator 0.32 7.74

Price Performance

Historical Comparison
VNRX
LCFY

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

Share on Social Networks: